Medifast, Inc.
MED
$13.68
-$0.41-2.91%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 602.46M | 674.48M | 770.18M | 897.81M | 1.07B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 602.46M | 674.48M | 770.18M | 897.81M | 1.07B |
| Cost of Revenue | 157.84M | 176.70M | 200.71M | 241.06M | 296.20M |
| Gross Profit | 444.62M | 497.77M | 569.48M | 656.75M | 775.85M |
| SG&A Expenses | 435.94M | 481.23M | 529.33M | 570.02M | 644.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 598.28M | 662.33M | 734.63M | 815.68M | 945.65M |
| Operating Income | 4.18M | 12.15M | 35.55M | 82.13M | 126.40M |
| Income Before Tax | 3.79M | 12.32M | 37.29M | 87.05M | 128.80M |
| Income Tax Expenses | 1.70M | 4.99M | 7.96M | 19.29M | 29.38M |
| Earnings from Continuing Operations | 2.09 | 7.33 | 29.33 | 67.76 | 99.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.09M | 7.33M | 29.33M | 67.76M | 99.41M |
| EBIT | 4.18M | 12.15M | 35.55M | 82.13M | 126.40M |
| EBITDA | 13.80M | 21.94M | 48.64M | 95.53M | 139.51M |
| EPS Basic | 0.19 | 0.67 | 2.69 | 6.22 | 9.14 |
| Normalized Basic EPS | 0.29 | 0.78 | 2.22 | 5.07 | 7.40 |
| EPS Diluted | 0.18 | 0.66 | 2.68 | 6.20 | 9.11 |
| Normalized Diluted EPS | 0.29 | 0.78 | 2.20 | 5.05 | 7.38 |
| Average Basic Shares Outstanding | 43.72M | 43.68M | 43.63M | 43.58M | 43.54M |
| Average Diluted Shares Outstanding | 43.85M | 43.80M | 43.76M | 43.74M | 43.68M |
| Dividend Per Share | -- | 0.00 | 1.65 | 3.30 | 4.95 |
| Payout Ratio | 34.18% | 255.16% | 125.26% | 80.52% | 73.45% |
